<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9347">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05699876</url>
  </required_header>
  <id_info>
    <org_study_id>AIIMS Delhi</org_study_id>
    <nct_id>NCT05699876</nct_id>
  </id_info>
  <brief_title>Melatonin vs Gabapentin for Post Trauma Surgery</brief_title>
  <official_title>A Comparative Study of Melatonin and Gabapentin as Premedication for Patients Undergoing Surgery Following Trauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to compare the effect of preoperative administration of melatonin and&#xD;
      gabapentin in reducing preoperative anxiety, stress markers and postoperative pain levels in&#xD;
      trauma patients undergoing surgery. Gabapentin has analgesic as well as sedative properties.&#xD;
      Melatonin, a hormone has been extensively used in intensive care units and has found to&#xD;
      improve the sleep cycle and reduce pain. It is now being explored as a preoperative&#xD;
      medication.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2023</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>preoperative anxiety</measure>
    <time_frame>30 minutes after drug administration</time_frame>
    <description>evaluate the difference in the preoperative anxiety score(Numerical Rating Scale ) before and after drug administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>inflammatory markers</measure>
    <time_frame>before and 30 minutes after drug administrartion</time_frame>
    <description>o The serum cortisol and IL6 levels (biochemical markers of stress) intraoperatively and postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation score</measure>
    <time_frame>before and 30 minutes after drug administrartion</time_frame>
    <description>Sedation score based on Observer Assessment of Alertness/Sedation Scale (OAA/S) before and after drug administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post operative analgesia</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>o Total fentanyl consumption 24 hours post-surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Anxiety, Preoperarative</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gabapentin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin 6 MG</intervention_name>
    <description>melatonin will be administered orally preoperatively as premedication</description>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>melatonin will be administered orally preoperatively as premedication</description>
    <arm_group_label>Gabapentin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: Patients will be recruited if they satisfy the following inclusion&#xD;
        criteria:&#xD;
&#xD;
          -  Age 18-65 years,&#xD;
&#xD;
          -  ASA score I-II,&#xD;
&#xD;
          -  Scheduled either for non-emergency surgery after trauma and&#xD;
&#xD;
          -  Presumptive duration of operation not exceeding 3 hours.&#xD;
&#xD;
        Exclusion criteria: The following patients will be excluded from the study:&#xD;
&#xD;
          -  Patients for emergency surgeries&#xD;
&#xD;
          -  Surgeries taking place after 1pm (to account for diurnal variation in cortisol levels)&#xD;
&#xD;
          -  Patients having altered mental state, history of psychiatric disorder, history of drug&#xD;
             abuse or those on chronic pain medication&#xD;
&#xD;
          -  Patients who have come for a repeat surgery and have already been included once in the&#xD;
             study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aiims</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>member secretary</last_name>
      <phone>91-11-265904579</phone>
      <email>ethicscommitteeaiims@aiims.ac.in</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 12, 2023</study_first_submitted>
  <study_first_submitted_qc>January 24, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2023</study_first_posted>
  <last_update_submitted>January 24, 2023</last_update_submitted>
  <last_update_submitted_qc>January 24, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>Kelika Prakash</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>melatonin</keyword>
  <keyword>gabapentin</keyword>
  <keyword>preoperative anxiety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

